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Poor people get cancer too  
To the Editor: Three articles in your July 2007 issue need to be 
brought together to reveal the bigger picture.
Sa’ad Lahri1 writes that the failure of a Third-World general 
practitioner to do a Pap smear is inexcusable and negligent. He 
appears not to appreciate the logistics of doing Pap smears in 
private general practice. The patient has to attend and pay a fee 
– perhaps R150 in the Third-World practice; the general practi-
tioner sends the slide to a pathologist who charges about R100; 
the patient then has to return for the result of the smear, making 
the cost for that service about R400.
Sydney Rosen et al.2 quantify the costs, including transport 
and loss of earnings, to patients of obtaining free antiretroviral 
drugs at state and charitable clinics. These costs, which are 
equally significant in Third-World private practice, must be 
added to the consultation and pathology fees. This is partly 
why, especially in the Third World, cancer patients present late 
in their disease process.
Ralph Kirsch3 deplores the Western Cape Department of 
Health’s budget reductions at the Groote Schuur and Tygerberg 
teaching hospitals, and the minimum 6 weeks’ delay before 
indigent cancer patients are treated. At the time of writing this 
letter, patients with carcinoma of the cervix wait 3 months for 
an appointment at the gynaecology outpatient department at 
Groote Schuur Hospital. It takes the National Public Health 
Laboratory 2 months to report Pap smears – a service done in 
2 days by private pathologists. Such patients therefore wait at 
least 5 months before being assessed, at which stage the cancer 
will probably be too far advanced for anything more than pal-
liation.
Whether we practise medicine in the First or the Third World, 
in the state or the private sector, money available for disease 
management is limited and fixed. Using waiting lists is the 
state’s method of rationing a service for which the demand 
cannot meet the supply. The National Health Service in the UK 
continues to use this technique after half a century.
Our political masters and health economist advisors appear 
to have decided that the limited funds are more cost-effectively 
spent on, for example, antiretroviral drugs for HIV-positive 
patients, thereby keeping them productive. In comparison the 
clinical and cost-efficacy prognosis for many neoplastic diseases 
is much worse. I am glad I do not have to make this difficult 
decision.
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Wynberg, Cape Town
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Simultaneous filarial infection of the 
pleura and breast 
To the Editor: Lymphatics are the most favoured site of 
filarial localisation, although Wuchereria bancrofti has been 
found in various atypical sites such as the thyroid, pericardial 
effusion, bone marrow, bronchial aspirate, etc.1 An unusual 
simultaneous involvement of the pleura and breast by W. 
bancrofti is presented.
A 30-year-old woman presented with a swelling in the 
left breast of 4 months’ duration, and left-sided chest pain, 
occasional dry cough and breathlessness on exertion for the 
past 3 weeks.
The breast lump was 3 x 2 cm in size, located in the upper 
inner quadrant of the left breast. It was slightly tender to the 
touch, firm in consistency and fixed, and the overlying skin 
was normal. Physical examination of the chest suggested a left-
sided pleural effusion.
Peripheral blood examination showed eosinophilia 
(eosinophils 18%, and absolute eosinophil count 1 296/µl). 
Pleural aspirate showed an exudative pattern, and cytological 
examination revealed a predominance of lymphocytes, 
few eosinophils, mesothelial cells and microfilariae. The 
microfilariae were sheathed and their terminal ends (tips) 
were devoid of nuclei, characteristic of W. bancrofti. Needle 
aspiration of the breast lump showed a chronic inflammatory 
infiltrate, with a few interspersed eosinophils, occasional 
granuloma formation and parts of gravid adult worm. A few 
microfilariae of W. bancrofti were also seen. A thick peripheral 
blood smear examination (nocturnal) showed numerous live 
microfilariae.
The patient was treated with di-ethyl-carbamazine citrate, at 
a dose of 6 mg/kg/day for 4 weeks. Following treatment there 
was complete resolution of the pleural effusion, breast lump 
and peripheral blood eosinophilia.
Filariasis is most commonly caused by W. bancrofti, 
transmitted by mosquitoes of the Cultex, Anopheles and Aedes 
genera. The adult worm resides in lymphatic channels, 
while microfilariae circulate in peripheral blood. It has been 
suggested2 that microfilariae appear in tissue fluids and 
exfoliated surface material due to lymphatic or vascular 
obstruction. The dead degenerating adult worms usually 
produce a severe inflammatory reaction (eosinophilic) and 
granuloma formation, whereas an intact healthy filarial worm 
may produce only a minimal reaction. Menon and Annamalai3 
proposed that living worm may also induce inflammatory 
changes in the surrounding tissue, explaining that ‘parturition 
of the female in a blocked vessel may be followed by a 
discharge of embryos in surrounding tissue, and this may 
probably initiate inflammatory changes’. The above hypothesis 
can be used to explain the microfilarial seeding of the pleura 
and breast in our case.
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